Rep. Greg Landsman: [Had WISeR] Gone Through Congress, It Would Not Have Passed

The Centers for Medicare & Medicaid Services recently launched the WISER model, an AI‑powered prior‑authorization system that automatically evaluates Medicare claims. The pilot is running in six states, including Ohio, and promises faster decisions but has already sparked confusion among providers and patients. Critics argue the algorithm can deny necessary treatments, leaving seniors without essential care while shifting cost savings to tech firms that operate the platform. As the program rolls out, hospitals report delayed reimbursements and clinicians struggle to understand opaque AI rulings, raising immediate operational challenges for the health‑care sector.

Congressman Greg Lansman contends that WISER bypassed the Congressional Review Act, a statutory check that should have forced a full legislative debate before any substantive Medicare change. The Government Accountability Office confirmed the pilot falls under the Act, giving lawmakers a legal foothold to intervene. Lansman has introduced legislation to terminate the pilot and require any future AI integration to receive explicit congressional approval. This move reflects growing bipartisan concern that unchecked AI could undermine patient safety and create regulatory loopholes, prompting a renewed focus on oversight mechanisms.

The backlash against WISER highlights a broader tension between innovation and accountability in U.S. health policy. While AI offers potential cost reductions, the episode underscores the risk of deploying technology without transparent governance, especially when senior populations are affected. For insurers, providers, and health‑tech investors, the situation signals heightened regulatory scrutiny and the need for robust compliance frameworks. Stakeholders are watching closely to see whether Congress will block the current pilot and set a precedent that any AI‑driven Medicare reform must first clear the legislative hurdle.